SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069) (TLSA) — Mar 1, 2022

Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)
Date: March 1, 2022 · CIK: 0001723069 · Accession: 0001213900-22-010018

AI Filing Summary & Sentiment

File numbers found in text: 333-252441

Date
March 1, 2022
Author
Not clearly detected
Form
CORRESP
Company
Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)

Letter

Tiziana Life Sciences Ltd.

55 Park Lane

London

W1k 1NA

March 1, 2022

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Alan Campbell

Re: Tiziana Life Sciences Ltd.

Amendment No. 1 to Form F-3 Registration Statement

Filed February 25, 2022

File No. 333-252441

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Tiziana Life Sciences Ltd. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Standard Time, on Thursday, March 3, 2022, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

TIZIANA LIFE SCIENCES LTD.

By: /s/ Kunwar Shailubhai

Name: Kunwar Shailubhai

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Tiziana Life Sciences Ltd.

55 Park Lane

London

W1k 1NA

    March 1, 2022

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Alan Campbell

    Re:
    Tiziana Life Sciences Ltd.

    Amendment No. 1 to Form F-3 Registration Statement

    Filed February 25, 2022

    File No. 333-252441

Ladies and Gentlemen:

Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended, Tiziana Life Sciences Ltd. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 4:00 p.m., Eastern Standard Time, on Thursday, March 3, 2022, or as soon thereafter as possible.

Please notify Jeffrey Fessler
of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.

    TIZIANA LIFE SCIENCES LTD.

    By:
    /s/ Kunwar Shailubhai

    Name:
    Kunwar Shailubhai

    Title:
    Chief Executive Officer